iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionStoneX Group Inc.
Latest Disclosed Ownership3,292 shares
Latest Disclosed Value $ 553,154
StoneX Group Inc. reports 18.76% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - StoneX Group Inc. filed a 13F-HR form disclosing ownership of 3,292 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $553,154 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,772 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 18.76% during the quarter. The current value of the position is $431,417 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,292 520 18.76 553 18.16 0.0298
2026-02-12 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,772 919 49.60 469 75.28 0.0203
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,853 -276 -12.96 268 -0.74 0.0117
2025-08-13 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,129 -15 -0.70 269 -1.82 0.0131
2025-08-13 2025-03-31 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,144 245 12.90 274 9.16 0.1118
2025-08-13 2024-12-31 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 1,899 -248 -11.55 251 -19.55 0.0993
2025-08-13 2024-09-30 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,147 91 4.43 313 10.64 0.1402
2025-08-13 2024-06-30 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,056 -14 -0.68 282 -0.70 0.1319
2025-08-13 2024-03-31 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,070 -32 -1.52 284 -0.35 0.1467
2025-08-13 2023-12-31 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,102 -154 -6.83 286 3.26 0.1525
2025-08-13 2023-09-30 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,256 -424 -15.82 276 -18.82 0.1527
2025-08-13 2023-06-30 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,680 -12 -0.45 340 -2.02 0.1918
2025-08-13 2023-03-31 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,692 -134 -4.74 348 -6.47 0.2068
2025-08-13 2022-12-31 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,826 -110 -3.75 371 8.16 0.0540
2025-08-13 2022-09-30 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 2,936 -1,613 -35.46 343 -35.89 0.0639
2025-08-13 2022-06-30 13F/A-2 ISHARES TR ISHARES BIOTECH 464287556 4,549 -1,801 -28.36 535 -35.31 0.0876
2025-08-13 2022-03-31 13F/A-4 ISHARES TR ISHARES BIOTECH 464287556 6,350 3,867 155.74 827 118.78 0.0782
2025-08-13 2021-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 2,483 248 11.10 379 4.71 0.0453
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,483 248 379 0.0453
2021-10-20 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,235 444 24.79 361 23.21 0.0519
2021-08-06 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,791 463 34.86 293 46.50 0.0435
2021-06-30 2021-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 1,328 1,328 200 0.0359
2019-07-17 2019-06-30 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 0 -1,798 -100.00 0 -100.00
2019-04-05 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,798 1,798 201 0.1530
2019-01-15 2018-12-31 13F ISHARES TR C 464287556 0 -2,002 -100.00 0 -100.00
2018-10-03 2018-09-30 13F ISHARES TR C 464287556 2,002 2,002 244 0.1811
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.